Search

The success of science, research, and medicine in saving and extending lives requires the transfer of ideas and knowledge in the laboratory, classroom, hospitals and clinics. The Executive Order issued on June 22 that suspends the issuing of temporary visas for certain foreign workers will only impede the innovation and scientific leadership that the world has come to expect from the United States.

… Wednesday, June 24, 2020 The success of science, research, and medicine in saving and extending lives requires the transfer of ideas and knowledge in the laboratory, classroom, hospitals and clinics. Shutting off access to the brightest and most talented scientists and clinicians from around the world

Karen Granville works as a patient advocate to increase their access to MSK for cancer treatment.

… Tuesday, March 8, 2022 An Advocate for Patients with Cancer As a registered nurse for the past 13 years, Karen Granville , who now serves as a Nurse Case Manager for Patient Financial Services at MSK, empathizes with the struggles faced by our patients with cancer. “It’s easy to lose hope,” Ms. Granville

Norwalk Hospital and Memorial Sloan Kettering Cancer Center (MSK) today announced MSK Physicians at Norwalk Hospital, a new cancer care collaboration that will integrate MSK medical and radiation oncologists and care practices with the existing cancer program at the C. Anthony and Jean Whittingham Cancer Center at Norwalk Hospital.

… Monday, October 16, 2017 Norwalk Hospital and Memorial Sloan Kettering Cancer Center (MSK) today announced MSK Physicians at Norwalk Hospital , a new cancer care collaboration that will integrate MSK medical and radiation oncologists and care practices with the existing cancer program at the C. Anthony

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for Cell Engineering, and Stephen and Barbara Friedman Chair, has been awarded the 2024 Breakthrough Prize in Life Sciences.

… Thursday, September 14, 2023 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Michel Sadelain, MD, PhD, renowned physician-scientist, Director of the Center for Cell Engineering, and Stephen and Barbara Friedman Chair, has been awarded the 2024  Breakthrough Prize in Life Sciences

Bevacizumab (Avastin®) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer, according to a new study. Results from the phase III "OCEANS" trial were presented today by the lead author, Carol Aghajanian, MD, of Memorial Sloan Kettering Cancer Center, at the 2011 annual meeting of the American Society of Clinical Oncology.

… Saturday, June 4, 2011 Bevacizumab (Avastin®) in combination with chemotherapy resulted in a clinical benefit for patients with recurrent ovarian cancer , according to a new study. Results from the phase III “OCEANS” trial were presented today by the lead author, Carol Aghajanian, MD , of Memorial Sloan

The FDA has approved an engineered cell therapy called afamitresgene autoleuecel (Tecelra®, also known as afami-cel) for treating advanced synovial sarcoma. The clinical trials resulting in the drug’s approval were led by Dr. Sandra D’Angelo of MSK.

… Friday, August 2, 2024 The U.S. Food and Drug Administration (FDA) has granted accelerated approval for the immunotherapy afamitresgene autoleucel (Tecelra ® , also known as afami-cel) for the treatment of adults with a rare soft tissue cancer called  synovial sarcoma . Afami-cel is the first engineered

A new imaging approach could shorten the time needed to determine whether a brain tumor treatment is working.

… Friday, July 13, 2018 Summary It is hard to monitor whether treatment for a brain tumor is having an effect. A new diagnostic technique called hyperpolarized MRI provides a clear image of the brain’s metabolic activity. This can give important clues about whether a treatment is working in a shorter time

New research from MSK investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies.

… Friday, May 24, 2024 New research from Memorial Sloan Kettering Cancer Center (MSK) investigates a promising approach against diabetic retinopathy and finds patients with early-onset colorectal cancer likely don’t need more frequent surveillance colonoscopies. Anti-ceramide immunotherapy promising against

American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering Cancer Center.

… Thursday, July 10, 2008 Blake Aims to Raise $1 Million for the Fund in Its Inaugural American tennis player and World No. 8 ranked James Blake will formally announce today the launch of the Thomas Blake, Sr., Memorial Research Fund, which he established to support cancer research at Memorial Sloan Kettering

Brain cancer is deadly because it’s so difficult to study. Scientist Luis Parada has developed an innovative model to analyze how brain tumors form and respond to treatment.

… Friday, January 1, 2021 Finding a treatment for brain tumors like glioblastoma (GBM) has been a heartbreaking challenge. The five-year survival rate is less than 10% for patients 45 and older. Because these tumors are relatively rare and located in such a sensitive and well-sheltered part of the body